Daniel Edward Vaughn,Douglas Boyer Muchmore,Gregory I. Frost
申请号：
US13507261
公开号：
US20130022592A1
申请日:
2012.06.15
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Provided are methods for continuous subcutaneous insulin infusion (CSII) that employ a hyaluronan-degrading enzyme, including a recombinant human PH20 (rHuPH20). The methods can be used to more consistently control blood glucose during the course of CSII. The methods can be used to treat subjects having diabetes or other insulin-associated disease or condition.
